Acadia Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
29.06.26
/
50%
€22.05
Target price
29.06.27
€31.62
Performance (%)
0.00%
Price
29.06.26
€22.05
Summary
This prediction is currently active. Canaccord_Genuity_Gr's BUY prediction for Acadia Pharmaceuticals is currently unchanged. This prediction currently runs until 29.06.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | 0.00% |
| iShares Core DAX® | -1.427% |
| iShares Nasdaq 100 | -1.979% |
| iShares Nikkei 225® | -3.848% |
| iShares S&P 500 | -0.472% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) had its price target raised by Canaccord Genuity Group Inc. from $32.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat